Acquisition

The MedicX Fund Limited
29 November 2006


For immediate release                                          29 November 2006


                              MedicX Fund Limited

                  ('MedicX Fund', 'the Fund' or 'the Company')


                         Acquisition - Major Expansion


MedicX Fund, the specialist investor in modern purpose built primary healthcare
properties which on 2 November 2006 listed on the Official List of the London
Stock Exchange today announces that it has agreed to acquire three new completed
primary care properties from Oakapple Primary Care Group for £9.43 million in
cash. The three sites in Fleetwood, Bradford and Doncaster which generate
£642,285 current income per annum in aggregate, have been valued by DTZ Debenham
Tie Leung, valuers to the MedicX Fund, at £11.55m, net of 5.75% purchaser costs.
The three new sites bring the total number of primary healthcare properties
owned by the MedicX Fund to 16 in total.


In addition, MedicX Fund has entered into a forward funding framework agreement
to forward fund, properties developed by Oakapple Primary Care Partnership up to
a minimum value of £50 million subject to available funds.


Under the forward funding framework agreement Oakapple Primary Care Partnership
is required to exclusively offer properties to the MedicX Fund for a minimum
period until 1st January 2009 which can be extended subject to agreement.


Keith Maddin, Chairman of MedicX Group said 'We are delighted to have completed
this acquisition with Leeds based Oakapple which represents a major expansion
for the MedicX Fund in the north of England and an exclusive pipeline of future
investment opportunities.'


The transaction was included within the MedicX Group's pipeline at the time of
the MedicX Fund's prospectus and is expected to complete on 11 December 2006.


                                      End


For further information please contact:

MedicX Group                                    [phone]

Keith Maddin, Chairman
Mike Adams, Managing Director

Buchanan Communications                         [phone]

Charles Ryland / Lisa Baderoon / Mary-Jane
Johnson




                      This information is provided by RNS
            The company news service from the London Stock Exchange